Clinical Trial Update: R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing R-CEOP-90/70 versus R-CHOP-50 for Diffuse large B-cell lymphoma and Follicular lymphoma grade 3B; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade 3b

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-cell Lymphoma, Follicular Lymphoma Grade 3B | Phase 3 | Status: UNKNOWN